PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding PAVmed Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 21 | 1 | 19 | −1 |
| Shares | 518.5K | 157 | 935.9K | +417.5K (+80.5%) |
| Value | $5.26M | $1.59K | $5.56M | +$297.7K (+5.7%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held PAVmed Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 75 | $446 | 0.00% |
| Federation des caisses Desjardins du Quebec | 4 | $23 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $6 | 0.00% |
| Royal Bank of Canada | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held PAVmed Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Byrne Asset Management LLC | 6,420 | $65.2K |
| Tower Research Capital LLC (TRC) | 622 | $6.31K |
| Vanguard Global Advisers, LLC | 61 | $619 |
| Group One Trading, L.P. | 2 | $20 |
| AdvisorNet Financial, Inc | 1 | $10 |
Not filed for Q2 2026 yet (1)
Institutions that held PAVmed Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 157 | $1.59K |